Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults
Published 2023 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Prevalence and Risk Factors of Metabolic Dysfunction-Associated Fatty Liver Disease with Renal Insufficiency in Overweight/Obese Adults
Authors
Keywords
-
Journal
Obesity Facts
Volume -, Issue -, Pages 1-11
Publisher
S. Karger AG
Online
2023-10-12
DOI
10.1159/000533626
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Association of metabolic dysfunction-associated fatty liver disease with kidney disease
- (2022) Ting-Yao Wang et al. Nature Reviews Nephrology
- Prevalence of advanced hepatic fibrosis and comorbidity in metabolic dysfunction‐associated fatty liver disease in Korea
- (2022) Mimi Kim et al. LIVER INTERNATIONAL
- Metabolic dysfunction-associated fatty liver disease predicts new onset of chronic kidney disease better than does fatty liver or nonalcoholic fatty liver disease
- (2022) Marenao Tanaka et al. NEPHROLOGY DIALYSIS TRANSPLANTATION
- Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults
- (2021) Jiaye Liu et al. Clinical Gastroenterology and Hepatology
- Prevalence of and risk factors for metabolic associated fatty liver disease in an urban population in China: a cross-sectional comparative study
- (2021) Yu-ling Chen et al. BMC GASTROENTEROLOGY
- Clinical Care Pathway for the Risk Stratification and Management of Patients With Nonalcoholic Fatty Liver Disease
- (2021) Fasiha Kanwal et al. GASTROENTEROLOGY
- Metabolic dysfunction-associated fatty liver disease is associated with increased all-cause mortality in the United States
- (2021) Donghee Kim et al. JOURNAL OF HEPATOLOGY
- Association between Body Mass Index and Chronic Kidney Disease in Asian Populations: A Participant-level Meta-Analysis
- (2021) Bjorn Kaijun Betzler et al. MATURITAS
- Prevalence and risk factors of metabolic associated fatty liver disease in the contemporary South China population
- (2021) Jiahua Fan et al. Nutrition & Metabolism
- Epidemiology and determinants of obesity in China
- (2021) Xiong-Fei Pan et al. Lancet Diabetes & Endocrinology
- Differential Clinical Characteristics and Mortality Outcomes in Persons With NAFLD and/or MAFLD
- (2021) Vy H. Nguyen et al. Clinical Gastroenterology and Hepatology
- Metabolic-associated Fatty Liver Disease (MAFLD): A Multi-systemic Disease Beyond the Liver
- (2021) Eda Kaya et al. Journal of Clinical and Translational Hepatology
- Abnormal liver enzymes: A review for clinicians
- (2021) M Ammar Kalas et al. World Journal of Hepatology
- MAFLD: A consensus-driven proposed nomenclature for metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. GASTROENTEROLOGY
- NAFLD as a driver of chronic kidney disease
- (2020) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- A new definition for metabolic dysfunction-associated fatty liver disease: An international expert consensus statement
- (2020) Mohammed Eslam et al. JOURNAL OF HEPATOLOGY
- What's in a name? Renaming ‘NAFLD’ to ‘MAFLD’
- (2020) Yasser Fouad et al. LIVER INTERNATIONAL
- The Asian Pacific Association for the Study of the Liver clinical practice guidelines for the diagnosis and management of metabolic associated fatty liver disease
- (2020) Mohammed Eslam et al. Hepatology International
- MAFLD and risk of CKD
- (2020) Dan-Qin Sun et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Non-invasive fibrosis scoring systems can predict future metabolic complications and overall mortality in non-alcoholic fatty liver disease (NAFLD)
- (2019) Kristina Önnerhag et al. SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY
- Nonalcoholic fatty liver disease increases risk of incident advanced chronic kidney disease: A propensity‐matched cohort study
- (2019) Haesuk Park et al. JOURNAL OF INTERNAL MEDICINE
- Prevalence, incidence, and outcome of non-alcoholic fatty liver disease in Asia, 1999–2019: a systematic review and meta-analysis
- (2019) Jie Li et al. Lancet Gastroenterology & Hepatology
- Higher liver stiffness scores are associated with early kidney dysfunction in patients with histologically proven non-cirrhotic NAFLD
- (2019) Dan-Qin Sun et al. DIABETES & METABOLISM
- Obesity as a Disease
- (2018) Jagriti Upadhyay et al. MEDICAL CLINICS OF NORTH AMERICA
- Mechanisms of NAFLD development and therapeutic strategies
- (2018) Scott L. Friedman et al. NATURE MEDICINE
- Obesity and nonalcoholic fatty liver disease: From pathophysiology to therapeutics
- (2018) Stergios A. Polyzos et al. METABOLISM-CLINICAL AND EXPERIMENTAL
- Health Effects of Overweight and Obesity in 195 Countries over 25 Years
- (2017) NEW ENGLAND JOURNAL OF MEDICINE
- Obesity
- (2017) Pedro González-Muniesa et al. Nature Reviews Disease Primers
- NAFLD: A multisystem disease
- (2015) Christopher D. Byrne et al. JOURNAL OF HEPATOLOGY
- Association of Non-alcoholic Fatty Liver Disease with Chronic Kidney Disease: A Systematic Review and Meta-analysis
- (2014) Giovanni Musso et al. PLOS MEDICINE
- A New Equation to Estimate Glomerular Filtration Rate
- (2013) Andrew S. Levey et al. ANNALS OF INTERNAL MEDICINE
- Epidemiology of alcoholic and nonalcoholic fatty liver disease in China
- (2013) Jian-Gao Fan JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance
- (2009) Nina F. Schwenzer et al. JOURNAL OF HEPATOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started